CH622703A5 - Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite - Google Patents

Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite Download PDF

Info

Publication number
CH622703A5
CH622703A5 CH734376A CH734376A CH622703A5 CH 622703 A5 CH622703 A5 CH 622703A5 CH 734376 A CH734376 A CH 734376A CH 734376 A CH734376 A CH 734376A CH 622703 A5 CH622703 A5 CH 622703A5
Authority
CH
Switzerland
Prior art keywords
acid
composition according
good
compound
cellulite
Prior art date
Application number
CH734376A
Other languages
English (en)
French (fr)
Inventor
A Renonce A Etre Mentionne Inventeur
Original Assignee
Berema Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berema Sa filed Critical Berema Sa
Priority to CH734376A priority Critical patent/CH622703A5/fr
Priority to FR7717842A priority patent/FR2354101A1/fr
Publication of CH622703A5 publication Critical patent/CH622703A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH734376A 1976-06-10 1976-06-10 Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite CH622703A5 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH734376A CH622703A5 (en) 1976-06-10 1976-06-10 Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite
FR7717842A FR2354101A1 (fr) 1976-06-10 1977-06-10 Preparation pour traiter les surcharges graisseuses et les infiltrats cellulitiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH734376A CH622703A5 (en) 1976-06-10 1976-06-10 Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite

Publications (1)

Publication Number Publication Date
CH622703A5 true CH622703A5 (en) 1981-04-30

Family

ID=4323632

Family Applications (1)

Application Number Title Priority Date Filing Date
CH734376A CH622703A5 (en) 1976-06-10 1976-06-10 Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite

Country Status (2)

Country Link
CH (1) CH622703A5 (ru)
FR (1) FR2354101A1 (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007380A1 (en) * 1987-03-25 1988-10-06 Pharmacia Ab A composition for the topical treatment of glaucoma or ocular hypertension
WO1989007454A1 (en) * 1988-02-11 1989-08-24 Ulf Per Gustav Smith Pharmaceutical composition for treatment of lung obstructions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587638A (en) * 1977-06-03 1981-04-08 Berema Sa Iodophenoxyphenylalkenoic acid derivatives and pharmaceutical preparations containing them
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
FR2649610B1 (fr) * 1989-07-13 1994-06-03 Dior Christian Parfums Composition cosmetique ou pharmaceutique et notamment dermatologique contenant de l'ampc ou ses derives en liposomes
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
EP0466909B1 (en) * 1990-02-05 1995-06-28 British Technology Group (Usa) Incorporated Thyroid hormone for cardiac treatment
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
DK0831769T3 (da) * 1995-06-07 2004-02-23 Karobio Ab Hidtil ukendte anvendelser af thyroideahormoner eller thyroideahormon-lignende forbindelser
GB0111314D0 (en) * 2001-05-09 2001-07-04 Karobio Ab Dermatological formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2139748B1 (ru) * 1971-06-03 1974-08-30 Theranol Lab
FR2142675A1 (en) * 1971-06-23 1973-02-02 Egema Sa Triiodothyroalkanoic acid derivs - for treating lipid overload and celluitis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007380A1 (en) * 1987-03-25 1988-10-06 Pharmacia Ab A composition for the topical treatment of glaucoma or ocular hypertension
AU609807B2 (en) * 1987-03-25 1991-05-09 Pharmacia Ab A composition for the topical treatment of glaucoma or ocular hypertension
US5079253A (en) * 1987-03-25 1992-01-07 Pharmacia Ab Composition for the topical treatment of glaucoma or ocular hypertension
WO1989007454A1 (en) * 1988-02-11 1989-08-24 Ulf Per Gustav Smith Pharmaceutical composition for treatment of lung obstructions

Also Published As

Publication number Publication date
FR2354101A1 (fr) 1978-01-06
FR2354101B1 (ru) 1980-02-15

Similar Documents

Publication Publication Date Title
CA2309304C (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
FR2651125A1 (fr) Compositions pharmaceutiques de type "pates a l'eau".
CH622703A5 (en) Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite
WO2004108063A2 (fr) Utilisation cosmetique des sophorolipides comme agents amincissants
FR2539992A1 (fr) Creme du type huile-dans-l'eau comprenant du butyro-propionate d'hydrocortisone, son procede de preparation et son application therapeutique
FR2514643A1 (fr) Lanolate de cuivre et compositions cosmetiques anti-acneiques le contenant
FR2490492A1 (fr) Composition cosmetique pour le traitement local de la cellulite
CA2099473C (fr) Composition cosmetique et/ou dermatologique a action depigmentante contenant un acide di- ou tri-cafeoylquinique ou un melange de ceux-ci
EP1480601B1 (fr) Utilisation cosmetique de la phytosphingosine comme agent amincissant et compositions cosmetiques contenant de la phytosphingosine
FR2607391A1 (fr) Composition prevenant le developpement a l'accoutumance pathologique a l'alcool
FR2733149A1 (fr) Nouvelles compositions cosmetiques amincissantes
EP1430883B1 (fr) Utilisation cosmétique de dérivés de l'acide ascorbique comme agents blanchissants de la peau ou des cheveux
EP2512420A2 (fr) Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée
Franco et al. Nitric oxide enhances prostaglandin production in ethanol-induced gastric mucosal injury in rats
FR2462909A1 (fr) Composition dermatologique a base de derives de l'acide apovincaminique ou d'apovincine et ses derives pour le traitement des maladies de la peau, accompagnees d'une proliferation cellulaire, telles que le psoriasis
EP0872244B1 (fr) Composition cosmétique ou pharmaceutique contenant un extrait d'Andiroba
CA2256947C (fr) Composition depigmentante destinee a l'eclaircissement de la peau et au traitement des taches pigmentaires
EP1317239B1 (fr) Associations synergiques a base de plantes pour traiter la chute des cheveux
WO2005023234A1 (fr) Utilisation de l’acide nor-dihydroguaiaretique en tant qu’inhibiteur de la formation adipocytaire humaine
FR2520230A1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
FR2547725A1 (fr) Compositions et procede de stabilisation de l'anthraline
WO2022157460A1 (fr) Procede d'amelioration de l'activite antioxydante de la vitamine c en solution aqueuse
JPH10182473A (ja) 皮下脂肪代謝促進剤及びそれを含む外用組成物
WO2002080877A2 (fr) Utilisation de l'alverine ou l'un de ses sels
FR2747308A1 (fr) Association de margousier, de (-) hydroxycitrate et de ceramides et compositions les renfermant

Legal Events

Date Code Title Description
PUE Assignment

Owner name: PREXCO PATENT ROYALTIES EXPLOITATION COMPANY LIMIT

PL Patent ceased